PURCHASE, N.Y.–(BUSINESS WIRE)–MBIA Inc. (NYSE:MBI) will host a webcast and conference call for investors on…
Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia…
NEWARK, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a…
Tumor outcomes and overall survival maintained in patients with HNC at one-year Cisplatin-related chronic kidney…
Partnership helps industrial customers improve asset monitoring and uptime optimization across multiple plants Radix-Element Partnership…
NICE Rapid is an exclusive company that provides silicone molding services and liquid silicone molding….
New York, New York–(Newsfile Corp. – October 26, 2022) – Cristhofer Munoz of LevelUp Academy…
DUBLIN–(BUSINESS WIRE)–The “Enterprise Application Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”…
iQor Leaders Explain How to Boost Performance Using the NICE Automation Platform ST. PETERSBURG, Fla.–(BUSINESS…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to seven classes of notes issued by Flagship Credit…
By Bastin Gerald, CEO and founder of Profit.co Their Importance and how to calculate them…
77% of early-stage relapsing-remitting multiple sclerosis (RRMS) patients who had not received prior treatment achieved…
Orion Corporation NOTIFICATION 26.10.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 26.10.2022 Date 26.10.2022…
VB10.NEO induced a T cell response in 95% of the patients, including expansion of both…
Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4%…
New study shows a man’s overall health, in combination with taking nutritional supplements, is associated…
Innovation Pharmaceuticals believes U.K. launch of MRgLITT for refractory focal epilepsy substantiates its investment in…
RESEARCH TRIANGLE PARK, N.C., Oct. 26, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage…
Combined with Ongoing Launch in Colorado, VLN® Will Be Available in All “Four Corners” States…
Daily dosing of fadraciclib was well tolerated; single agent activity observed across multiple tumor types including…